TY - JOUR
T1 - Weight gain and lifestyle risk factors for developing metabolic syndrome
AU - Atlantis, Evan
AU - Taylor, Anne W.
AU - Wittert, Gary
AU - Shi, Zumin
PY - 2014
Y1 - 2014
N2 - The metabolic syndrome (MetS) is characterized by a clustering of individual risk factors for cardiovascular disease and type 2 diabetes mellitus. These risk factors include high blood pressure, high fasting glucose, dyslipidemia (high triglycerides and low high-density lipoprotein cholesterol [HDL]), and central obesity. Clinical definitions of the MetS, proposed by the International Diabetes Federation (IDF) and the American Heart Association/National Heart, Lung, and Blood Institute (AHA/NHLBI), include 3 of these 5 abnormalities. Population-based studies estimate that 10–30% of adults have variably defined MetS. The MetS is associated with an increased risk of cardiovascular disease/events, allcause mortality (1.5-fold), and type 2 diabetes (>4-fold), as well as increased health costs. Thus, effective treatment and prevention of MetS could yield significant health and economic benefits worldwide. In addition, identification of the main risk factors for the MetS is required to generate research evidence of effectiveness to inform guidelines and practice.
AB - The metabolic syndrome (MetS) is characterized by a clustering of individual risk factors for cardiovascular disease and type 2 diabetes mellitus. These risk factors include high blood pressure, high fasting glucose, dyslipidemia (high triglycerides and low high-density lipoprotein cholesterol [HDL]), and central obesity. Clinical definitions of the MetS, proposed by the International Diabetes Federation (IDF) and the American Heart Association/National Heart, Lung, and Blood Institute (AHA/NHLBI), include 3 of these 5 abnormalities. Population-based studies estimate that 10–30% of adults have variably defined MetS. The MetS is associated with an increased risk of cardiovascular disease/events, allcause mortality (1.5-fold), and type 2 diabetes (>4-fold), as well as increased health costs. Thus, effective treatment and prevention of MetS could yield significant health and economic benefits worldwide. In addition, identification of the main risk factors for the MetS is required to generate research evidence of effectiveness to inform guidelines and practice.
UR - http://handle.uws.edu.au:8081/1959.7/544087
U2 - 10.1253/circj.CJ-14-0324
DO - 10.1253/circj.CJ-14-0324
M3 - Article
SN - 1346-9843
VL - 78
SP - 1066
EP - 1068
JO - Circulation Journal
JF - Circulation Journal
IS - 5
ER -